About Anthony Tufaro
Form D filings for Flow Pharma in 2024 list Anthony Tufaro as director.
Anthony Tufaro first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Anthony Tufaro in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Anthony Tufaro works with at each company, as listed on that company's latest Form D.
Flow Pharma, Inc. · Form D/A, Aug 8, 2024
PS
Pamela Steele
Director
RR
Reid Rubsamen
Chief Executive Officer and director
TB
Tikoes Blankenberg
Director
BO
Babatunde Otulana
Director